Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Hui Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9780-0845; OpenAlex author ID A5100681804. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 4

  1. ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth. Co-author DOI 10.1038/s42003-025-07897-0↗
  2. Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment. Co-author DOI 10.1016/j.biopha.2023.114567↗
  3. Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic… First author DOI 10.1038/s41598-023-40560-4↗
  4. Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in … Co-author DOI 10.18632/oncotarget.7078↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wei Mei Guo · 2 shared papers, 2023–2025 · strength 0.42
  2. Zhiqing Lin · 2 shared papers, 2023–2025 · strength 0.42
  3. Yuefeng Wang · 1 shared paper, 2023 · strength 0.26
  4. Hongdong Wang · 1 shared paper, 2023 · strength 0.26
  5. Xin Liu · 1 shared paper, 2023 · strength 0.15
  6. Peng Zhang · 1 shared paper, 2023 · strength 0.15
  7. Jianmin Wu · 1 shared paper, 2023 · strength 0.15
  8. Keke Huang · 1 shared paper, 2023 · strength 0.15
  9. Mincong Wang · 1 shared paper, 2016 · strength 0.05
  10. Chunli Li · 1 shared paper, 2016 · strength 0.05
  11. Tao Wu · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.